当前位置:首页 - 行情中心 - 森萱医药(920946) - 财务分析 - 现金流量表

森萱医药

(920946)

  

流通市值:45.15亿  总市值:45.17亿
流通股本:4.27亿   总股本:4.27亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金297,898,059.78142,188,427.6522,434,006.33380,143,964.06
  收到的税费返还117,000.0126,943.37144,161.95140,946.18
  收到其他与经营活动有关的现金2,440,644.61,213,219.1813,075,320.8913,197,695.46
  经营活动现金流入小计300,455,704.39143,428,590.15535,653,489.17393,482,605.7
  购买商品、接受劳务支付的现金80,123,133.3438,149,964.73151,798,280.77112,416,302.75
  支付给职工以及为职工支付的现金64,340,425.1837,193,726.14110,745,302.7285,106,146.75
  支付的各项税费30,255,131.549,946,215.7955,053,150.8143,733,657.92
  支付其他与经营活动有关的现金12,094,657.824,998,643.2821,298,401.6116,152,357.02
  经营活动现金流出小计186,813,347.8890,288,549.94338,895,135.91257,408,464.44
  经营活动产生的现金流量净额113,642,356.5153,140,040.21196,758,353.26136,074,141.26
二、投资活动产生的现金流量:
  收回投资收到的现金204,000,00088,000,000303,000,000207,000,000
  取得投资收益收到的现金2,930,611.62700,197.572,363,840.691,435,394.92
  处置固定资产、无形资产和其他长期资产收回的现金净额--1,800-
  收到的其他与投资活动有关的现金20,000,000---
  投资活动现金流入小计226,930,611.6288,700,197.57305,365,640.69208,435,394.92
  购建固定资产、无形资产和其他长期资产支付的现金9,781,833.775,196,722.69,590,535.476,522,124.32
  投资支付的现金222,000,000104,000,000376,000,000306,000,000
  支付其他与投资活动有关的现金74,000,00034,000,00091,000,00071,000,000
  投资活动现金流出小计305,781,833.77143,196,722.6476,590,535.47383,522,124.32
  投资活动产生的现金流量净额-78,851,222.15-54,496,525.03-171,224,894.78-175,086,729.4
三、筹资活动产生的现金流量:
  取得借款收到的现金13,000,0003,000,000-200,000
  收到其他与筹资活动有关的现金--200,000-
  筹资活动现金流入小计13,000,0003,000,000200,000200,000
  偿还债务支付的现金200,000200,000--
  分配股利、利润或偿付利息支付的现金72,351,517.7312,75062,968,567.662,968,567.6
  其中:子公司支付给少数股东的股利、利润4,000,000-3,200,0003,200,000
  支付其他与筹资活动有关的现金1,177,799.41133,0181,267,653.691,194,635.69
  筹资活动现金流出小计73,729,317.14345,76864,236,221.2964,163,203.29
  筹资活动产生的现金流量净额-60,729,317.142,654,232-64,036,221.29-63,963,203.29
四、汇率变动对现金及现金等价物的影响-3,233,563.25-1,356,308.31-1,937,713.43-1,223,900.33
五、现金及现金等价物净增加额-29,171,746.03-58,561.13-40,440,476.24-104,199,691.76
  加:期初现金及现金等价物余额542,877,681.42542,877,681.42583,318,157.66583,318,157.66
  期末现金及现金等价物余额513,705,935.39542,819,120.29542,877,681.42479,118,465.9
补充资料:
  净利润94,800,257.18-137,770,973.41-
  资产减值准备1,486,230.76-8,929,731.82-
  固定资产和投资性房地产折旧21,577,064.02-46,260,183.39-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧21,577,064.02-46,260,183.39-
  无形资产摊销580,180.77-1,162,341.74-
  处置固定资产、无形资产和其他长期资产的损失---2,615.92-
  固定资产报废损失5,273.58-574,522.03-
  公允价值变动损失-1,117,186.84--1,754,904.05-
  财务费用2,953,861.33--1,773,658.54-
  投资损失-492,376.96--959,285.82-
  递延所得税448,493-1,952,934.65-
  其中:递延所得税资产减少413,048.07--604,181.12-
    递延所得税负债增加35,444.93-2,557,115.77-
  存货的减少12,718,022.41-3,139,917.31-
  经营性应收项目的减少-5,291,830.65--9,497,360.2-
  经营性应付项目的增加-17,288,836.03-8,195,351.81-
  其他2,544,035.45-2,182,163.11-
  不涉及现金收支的投资和筹资活动金额其他项目2,892,757.55-1,093,854.7-
  现金的期末余额513,705,935.39-542,877,681.42-
  减:现金的期初余额542,877,681.42-583,318,157.66-
  现金及现金等价物的净增加额-29,171,746.03--40,440,476.24-
公告日期2026-08-262026-04-292026-04-222025-10-29
审计意见(境内)标准无保留意见
TOP↑